🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Caused by Toxoplasma gondii, toxoplasmosis is mostly asymptomatic except in...
Status
Completed
Location
Hopital Louis Mourier
Start Date
2018-06-20
Trial ID
NCT03385499
Treatments Being Tested
Adaptive immune responses are essential for clearing viral infections and r...
Status
Completed
Location
Hôpital Robert Debré
Start Date
2021-06-07
Trial ID
NCT04916847
Treatments Being Tested
This study is being done because the study doctor is trying to develop a ne...
Status
Terminated
Location
Northwestern Memorial Hospital
Start Date
2008-02
Trial ID
NCT01334281
Treatments Being Tested
This phase I trial studies the safety and the ability to expand laboratory-...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2003-06
Trial ID
NCT00228358
This study evaluates the efficacy and safety of an individualized preventiv...
Status
Unknown
Location
Hospital Universitari de Bellvitge
Start Date
2020-06-12
Trial ID
NCT04278547
Treatments Being Tested
The aim of this study is to determine a comprehensive immune profile of tra...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10-05
Trial ID
NCT01150487
Treatments Being Tested
This is a clinical trial comparing the immunosuppressive treatment determin...
Status
Unknown
Location
Hospital Universitari de Bellvitge
Start Date
2017-11-10
Trial ID
NCT03465397
Treatments Being Tested
Special populations are people with a risk to dévelop severe forms of a dis...
Status
Completed
Location
Centre Georges Francois Leclerc
Start Date
2021-06-02
Trial ID
NCT04935528
Treatments Being Tested
Current data in the literature demonstrate that the immune response to CoV-...
Status
Terminated
Location
CHU Saint-Etienne
Start Date
2021-03-09
Trial ID
NCT04648709
Treatments Being Tested